Research article. Journal of Biotechnology and Biosafety Volume 4, Issue 6, November-December 2016,

Similar documents
What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

Polycystic Ovarian Syndrome (PCOS) LOGO

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

Overview of Reproductive Endocrinology

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

F REQUENTLY A SKED Q UESTIONS

Polycystic Ovary Syndrome

Polycystic ovary syndrome

PCOS and Obesity DUB is better treated by OCPs

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO

Polycystic Ovary Syndrome (PCOS):

What is polycystic ovary syndrome? What are polycystic ovaries? What are the symptoms of PCOS?

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

2-Hypertrichosis:- Hypertrichosis is the

ASSOCIATION OF ANXIETY DISORDER IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME Sumbul Sohail 1, Rubina Salahuddin 1, Shabnum Nadeem 1

9.4 Regulating the Reproductive System

Polycystic ovary syndrome (PCOS)

Prof.Dr. Nabil Lymon Head of Internal Medicine Department

Information for you. What is polycystic ovary syndrome? Polycystic ovary syndrome: what it means for your long-term health

Abnormal Uterine Bleeding Case Studies

SAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:

New PCOS guidelines: What s relevant to general practice

AN AETIOLOGICAL STUDY OF MODERATE TO SEVERE HIRSUTISM

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology

Hormonal Control of Human Reproduction

The Impact of Insulin Resistance on Long-Term Health in PCOS

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome (PCOS)

On Diseases Of Menstruation And Ovarian READ ONLINE

lactotrophs 120 min- FSH 60 min- LH Hypothalamus GnRH pituitary Estradiol +/- Progesterone _ FSH L H Ovary Uterus Ovulation Antral follicle >2mm

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center

10.7 The Reproductive Hormones

CASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?

Reproductive Health and Pituitary Disease

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015

Therapeutic Cohort Results

Infertility for the Primary Care Provider

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

Bio 12- Ch. 21: Reproductive System

International Academy of Engineering and Medical Research, 2018 Volume-3, Issue-1 Published Online January 2018 in IAEMR (

1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.

One Day Hormone Check

Female Reproductive Endocrinology

OVERVIEW. FEMM (Fertility Education & Medical Management) is headquartered in New York City, NY. 1

Polycystic ovarian disease and Endometriosis

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital

Amenorrhoea: polycystic ovary syndrome

Determining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs)

The menstrual Cycle. François Pralong

POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist

PharmaTutor PRINT ISSN: E-ISSN:

Polycystic Ovary Syndrome

PCOS guidelines: What s relevant to general practice

Hormone. Free Androgen Index. 2-Hydroxyestrone. Reference Range. Hormone. Estrone Ratio. Free Androgen Index

The beginning of puberty is marked by the progressive increase in the production of sex hormones.

Does Ovarian Cysts affect your Fertility?

Chapter 14 Reproduction Review Assignment

The menstrual cycle. François Pralong

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS

Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle?

GONADAL FUNCTION: An Overview

Can Sex hormone Binding Globulin Considered as a Predictor of Response to Pharmacological Treatment in Women with Polycystic Ovary Syndrome?

Female Reproductive System. Lesson 10


Polycystic Ovary Syndrome

Estrogen Dominant Conditions Part I

Reproductive Hormones

Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies

Abstract. Introduction. RBMOnline - Vol 10. No Reproductive BioMedicine Online; on web 15 November 2004

SCREENING OF POLYCYSTIC OVARIAN SYNDROME AMONG ADOLESCENT GIRLS AT CAIRO UNIVERSITY

Endocrine and Reproductive Systems. Chapter 39: Biology II

Age and Fertility. A Guide for Patients Revised 2012 Copyright 2012 by the American Society for Reproductive Medicine

THE PREVALENCE AND ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME (PCOS) AS A CAUSE OF FEMALE INFERTILITY IN CENTRAL TRAVANCORE

Difference Between PCOS and Endometriosis

Hormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary

Gonadotrophin treatment in patients with Polycystic Ovary Syndrome

INFERTILITY CAUSES. Basic evaluation of the female

13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH

Reproductive FSH. Analyte Information

From the editors desk

Reproductive physiology

One Day Hormone Check

16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes

REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W

Re: Manuscript number: Polycystic ovary syndrome controversy: are expanding disease definitions unnecessarily labelling women with PCOS?

Infertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications and Surgery

International Journal of Current Medical And Applied Sciences.vol.1. Issue: 1, 2013, PP 11-15

Prevalence of polycystic ovarian syndrome in the Buraimi region of Oman

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016

WHY INVESTIGATE FOR INFERTILITY

Transcription:

PREVALENCE &RISK FACTORS OF POLYCYSTIC OVARY SYNDROME Research article Fatima Qamar, Safila Naveed, Saba M. Ishtiaq, Shaheen Kausar 1 Faculty of Pharmacy, Jinnah University For Women Corresponding Author: fatimamudassar2009@hotmail.com safila117@yahoo.com ABSTRACT Health of women is regarding the precaution, protecting, finding, as well as treatment of diseases that are interesting to women. Polycystic ovary disorder (PCOS) is significantly predominant and likely constitutes the most often experienced diseases of endocrine in women of conceptive age. PCOS is a typical issue among high-schooled young girls and young women. Actually, about 1 out of 10 woman has PCOS. Our objective is to assess prevalence and the risk factors of polycystic ovary disorder (PCOS) in women of Karachi, Pakistan. This is a cross-sectional questionnaire-based study with a stratified sampling technique. A questionnaire was designed and distributed in a sample size of 100 in order to assess prevalence and factors of polycystic ovary disorder (PCOS). After the collection of data the result was evaluated. The outcome results indicated that PCOS is more prevalent in single and young women. There is significantly increased number of women with the positive family history of diabetes. PCOS is the most well known problem, which influences the conceptive period of numerous women. Since 1 out of 10 and 1 out of 20 women of childbearing age has PCOS, it is basic that women are very much educated. Doctor can deal it with. Be that as it may, keeping up a sound and dynamic way of life may diminish the possibility of building up this condition. KEYWORDS: PCOS, obsessions, young girls, young Women, prevalence, risk factors. INTRODUCTION Polycystic ovary disorder (PCOS) is a heterogeneous endocrine disorder that affects women s reproductive age. It is associated with hper-androgenism (hirutism, acne and androgen dependent alopecia) and chronic an ovulation (amenorrhea, infertility, irregular dysfunctional uterine bleeding) (Franks 1995). Polycystic ovaries are described on ultrasound by the closeness of at least eight sub-capsular follicular bruises 10 mm and extended ovarian stroma. These movements, regardless, can be accessible in ladies who are totally endocrinologically ordinary. The reason for Polycystic ovary issue (PCOS) remain unknown (Polson, Wadsworth et al., 1988; Franks 1995) but studies shows that it occur due to genetic and environmental factors (Diamanti- Kandarakis, Kandarakis et al., 2006). PCOS seems to continue running in families, so likelihood of having it is higher have unusual periods or diabetes or if other women in family have it. PCOS can be delivered from either mother's or father's side (Clayton, Ogden et al., 1992). Women with PCO have irregularities in the metabolic system of androgens and estrogen as well as in the control of creation of androgen. High concentrations of androgenic hormones in serum, for instance, testosterone, androstenedione, and dehydro-epi-androsterone sulfate (DHEA-S), may be knowledgeable about these patients. Regardless, singular variety is broad, and a particular patient has typical androgen levels. PCOS is moreover associated with fringe insulin resistance and increase insulin in blood, as well as obesity builds the level of both varieties from the standard. Insulin resistance in PCOS can be assistant to a post-binding defect in signaling

pathways of insulin receptor, and raised levels of insulin may have gonadotropin-growing outcomes for ovarian limit. Increase insulin in blood may likewise bring about concealment of hepatic era of sex hormone binding globulin (SHBG), which thus lyandrogenicity may extend androgenicity (Ramlau-Hansen 2007). Polycystic ovaries are extended equally and have a smooth, thickened container that is a vascular. On cut portions, sub capsular follicles in various periods of atresia are found in the peripheral part of the ovary. The most striking ovarian component of PCOS is hyperplasia of the theca stromal cells including caught follicles. On moment examination, luteinized theca cells are seen (Toulis, Goulis et al., 2009). Women with PCOS might be at expanded hazard for cerebro-vascular and cardiovascular infection. Hoisted serum lipoprotein levels like those of men are in women with hyper androgenism (Conway, Agrawal et al., 1992; Christian, Dumesic et al., 2003). Not everyone with PCOS has polycystic ovaries (PCO), nor does everyone with ovarian developments have PCOS; in spite of the way that a pelvic ultrasound is a significant analytic tool (Oliveira, Sampaio et al., 2010). Other reasons for irregular or absent period and hirsutism, for example, inborn adrenal hyperplasia (21-hydroxylase lack), hyper prolactinemia, hypothyroidism, androgen emitting neoplasms, Cushing's disorder, and other pituitary or adrenal issue, ought to be researched (Teede, Deeks et al., 2010). The essential treatment for PCOS include: way of life changes, medicines aa well as surgery. Treatment objectives might be considered under four classifications: Rebuilding of fertility, bringing down of insulin resistance levels, rebuilding of regular menstruation, treatment of hirsutism or skin break out, and aversion of hyperplasia of endometrium and disease of endometrium (Lim and Wong 2010). The pharmacological treatment of PCOS is oral contraceptives as well as metformin. The mechanism of oral contraceptives is to increment sex hormone restricting globulin generation, which expands binding of testosterone. This decreases side effects of hirsutism brought about by increase level of testosterone and manages come back to normal menstrual cycle. Metformin, a medication generally utilized as a part of sort 2 diabetes to diminish insulin resistance. In certain cases, metformin also provide ovarian function as well as bring back to normal ovulation (Lord, Flight et al., 2003). METHODOLOGY Study Design. The retrospective study was performed to assess prevalence and the risk factors of polycystic ovary disorder (PCOS) in women of Karachi, Pakistan which incorporate 18 questions. It occurred over 3-months of August, September and October 2016. The study was conducted over a population of Karachi for the collection of data on PCOS. Participants 100 study subjects were selected from a random population of Karachi who are suffering from PCOS. Only females were included so as to exclude variations due to sex. Data Analysis The data collected through questionnaire which was coded, entered and analyzed using Excel in to order assess PCOS. RESULTS Socio-demographic characteristics of respondents The study includes total number of 100 individuals including female of all age groups 15-25 years (20%), 26-35 years (30%), 36-45 years (25%), 46-55 years (14%), above 55 years (11%) having weight >50kg (25%) and <50kg (75%) in which (60%) were single and (40%) were married. (Table 1). Symptoms &Risk factors of PCOS The retrospective study analysis was performed using Excel which represented statistically significant results that 5% of individuals desire carbohydrates & sugar, 80% Continuous weight gain, 90% had Irregular periods, 60% had excess facial hair, 18% Felt extremely hungry, Irritable, sleepy, or fatigued after eating sweets, 22% had Skin color changes or pigmentation, 13% had unusual amount of hair on breasts, 9% had Unusual hair growth on upper thighs, 23% had hypothyroidism, 66% had worst acne (Table 2.). While 75% individuals had family history of diabetes, 50% had Family history of irregular periods, 20% had family history of CVS, 10% had family history of thyroid disease (Figure 1).

Table 1: Socio-demographic characteristics of respondents Age 15-25 years 20% 26-35 years 30% 36-45 years 25% 46-55 years 14% > 55 years 11% Weight <50kg 25% >50kg 75% Marital Status Single 60% Married 40% Table 2: Symptoms of PCOS Questions Crave/desire carbohydrates & sugar 5% Continuous weight gain 80% Irregular periods 90% excess facial hair 60% Feel extremely hungry, Irritable, sleepy, or fatigued after eating sweets 18% Skin color changes or pigmentation 6% unusual amount of hair on breasts 13% Unusal hair growth on upper thighs 9% Hypothyroidism 23% Worst acne 66% Figure 1: Risk Factors of PCOS

DISCUSSION Results of our study shows that PCOS is the most common health problem and is more prevalent in single and young women. The most well-known manifestations are irregular periods, continuous weight raise up, worst acne as well as overabundance facial hair and most common risk factor of PCOS is family history of diabetes as well as family history of irregular periods. In PCOS, compensatory mechanism of increase insulin in blood realizes pleiotropic impacts including adrenal steroidogenesis and co-gonadotrophic incitement of ovarian; in T2D, contribution of insulin resistance towards β-cell is exhaustion and in the long run to low secretion of insulin with result of dysglycemia. The association among PCOS and DM type 1 is acknowledged to include supra-physiological unions of insulin inside the circulation of system. In women with PCOS, different little follicles gather in the ovary. None of these little follicles are prepared for creating to a size that would initiate ovulation. In this way, the estrogen levels, progesterone, LH, as well as FSH get the opportunity to be imbalanced. Androgens may get the opportunity to be extended in women with PCOS in perspective of the elevated measures of LH. In the event that ovulation does not occur, the uterus covering (called the endometrium) does not reliably shed as well as regrow as in normal menstrual cycle Or maybe, the endometrium gets the chance to be thicker along with shed irregularly, which can realize substantial and additionally drawn out dying. Unpredictable or missing menstrual periods can construct a women's peril of plenitude of endometrium (called hyperplasia of endometrium) or even endometrial development. CONCLUSION PCOS is a wellbeing condition, which influences numerous women in today's general public. Our knowledge about PCOS still stays unclear. Despite everything we have not think of a definition or an indicative basis for it. Being a standout amongst the most well-known endocrine issue in women, it reveals that we have to increase our knowledge on the management of the disease and in addition on the basic pathogenesis related to the disease. Despite the fact that medications for PCOS are genuinely powerful yet our knowledge of the basic pathogenesis is for all intents and purposes absent. Be that as it may, keeping up a solid and dynamic way of life may diminish the shot of building up this condition. REFERENCES Christian, R. C., D. A. Dumesic, T. Behrenbeck, A. L. Oberg, P. F. Sheedy and L. A. Fitzpatrick (2003). "Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome." The Journal of Clinical Endocrinology & Metabolism 88(6): 2562-2568. Clayton, R., V. Ogden, J. Hodgkinson, L. Worswick, D. Rodin, S. Dyer and T. Meade (1992). "How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?" Clinical endocrinology 37(2): 127-134. Conway, G. S., R. Agrawal, D. Betteridge and H. Jacobs (1992). "Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome." Clinical endocrinology 37(2): 119-125. Diamanti-Kandarakis, E., H. Kandarakis and R. S. Legro (2006). "The role of genes and environment in the etiology of PCOS." Endocrine 30(1): 19-26. Franks, S. (1995). "Polycystic ovary syndrome." New England Journal of Medicine 333(13): 853-861. Lim, C. E. and W. S. Wong (2010). "Current evidence of acupuncture on polycystic ovarian syndrome." Gynecological Endocrinology 26(6): 473-478. Lord, J. M., I. H. Flight and R. J. Norman (2003). "Metformin in polycystic ovary syndrome: systematic review and meta-analysis." Bmj 327(7421): 951. Oliveira, A., B. Sampaio, A. Teixeira, C. Castro-Correia, M. Fontoura and J. L. Medina (2010). "Polycystic ovary syndrome: Challenges in adolescence." Endocrinología y nutrición 57(7): 328-336. Polson, D., J. Wadsworth, J. Adams and S. Franks (1988). "Polycystic ovaries a common finding in normal women." The Lancet 331(8590): 870-872. Ramlau-Hansen, C. H. (2007). Prenatal Tobacco Exposure and Other Life-style Related Risk Factors for Low Semen Quality and Subfecundity: Epidemiologic Studies in Denmark: PhD Thesis, Department of Occupational Medicine, Aarhus University Hospital.

Teede, H., A. Deeks and L. Moran (2010). "Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan." BMC medicine 8(1): 41. Toulis, K., D. Goulis, D. Farmakiotis, N. Georgopoulos, I. Katsikis, B. Tarlatzis, I. Papadimas and D. Panidis (2009). "Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis." Human reproduction update 15(3): 297-307. Citation of this article: Fatima Qamar, Safila Naveed, Saba M. Ishtiaq, Shaheen Kausar. PREVALENCE &RISK FACTORS OF POLYCYSTIC OVARY SYNDROME. 4(6): 439-443. Source of Support: Nil Conflict of Interest: None Declared